Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
A Single-Nucleotide Polymorphism in the Gene Encoding Osteoprotegerin Is Associated With Diastolic Blood Pressure in Older Men
American Journal of Hypertension, 10/28/09
Golledge J et al. – This study suggests that a SNP within the region encoded by TNFRSF11B, which is believed to code for OPG, is associated with blood pressure. The mechanism underlying this observed association is currently unclear.
Jonathan Golledge, 10/28/09
| This study suggests an association between variation in the gene coding for the bone protein osteoprotegerin (OPG) and blood pressure. The finding maybe relevant to the know association between elevated circulating levels of OPG and cardiovascular events. |
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
Arthritis Care and Research , 11/03/09
Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Cardiovascular Drugs and Therapy, 11/03/09
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/23/09
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Current options for the treatment of resistant hypertension
Expert Review of Cardiovascular Therapy , 11/13/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


